Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ec-18 (1 trial)
ingap peptide (3 trials)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Mucositis (Phase 2)
Stomatitis (Phase 2)
Trials (4 total)
Trial APIs (2 total)